Department of Cardiology, Austin Health, Heidelberg.
Department of Medicine, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Victoria, Australia.
Curr Opin Lipidol. 2021 Jun 1;32(3):167-174. doi: 10.1097/MOL.0000000000000749.
The purpose of this review is to outline the relationship between cardiovascular disease (CVD) and depression, both as a cause of and a result of CVD.
The prevalence of depression seems to be increasing in the general population.It is likely that depression will be even more of a problem for CVD patients in the post-COVID-19 pandemic era.New studies confirm the independent association of depression with later incident CVD, although perhaps not as strong as suggested by some previous studies.Depression seems to be becoming even more prevalent in CVD patients, with new data for stroke and peripheral arterial disease patients.Cardiologists rarely screen for depression and most do not believe that they have a responsibility for detecting or treating depression.There are new data suggesting that patients who are more in control of their lives have better outcomes and that change is possible.
Depression is preventable and treatable. It is imperative to detect and manage depression in CVD patients. Additional research is required to see whether or not comprehensive patient screening for depression translates into both better quality of life and improved clinical outcomes.
本文旨在概述心血管疾病(CVD)与抑郁症之间的关系,包括二者相互作为病因和结果的情况。
抑郁症在普通人群中的发病率似乎呈上升趋势。在 COVID-19 大流行后时代,抑郁症对于 CVD 患者来说可能更是一个问题。新研究证实了抑郁症与随后发生的 CVD 之间存在独立关联,但可能不如一些先前研究提示的那样强。在 CVD 患者中,抑郁症的发病率似乎更高,新数据涉及卒中和外周动脉疾病患者。心脏病专家很少对抑郁症进行筛查,大多数人也不认为他们有责任发现或治疗抑郁症。有新数据表明,对生活更有掌控感的患者预后更好,而且这种变化是可能的。
抑郁症是可预防和可治疗的。对 CVD 患者进行抑郁检测和管理至关重要。需要进一步研究,以确定对抑郁症进行全面患者筛查是否能同时提高生活质量和改善临床结局。